POSTER SESSION IV
Tuesday, March 10, 2009 — 1:00 PM - 4:30 PM
Hynes CC Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
221
Evaluation of 18 miRNAs in Non-Small Cell Lung Carcinoma According to Its Clinical Stage
(1632)
A Quera, A Navarro, A Huerta, R Marrades, N Vinolas, M Monzo, J Ramirez - Hospital Clinic, Barcelona, Spain; Facultat Medicina UB, Barcelona, Spain
MicroRNA Biomarkers for Differential Diagnosis of Lung Tumors
(1630)
M Perelman, S Rosenwald, Y Spector, L Cohen, E Meiri, Z Bentwich, R Aharonov, I Barshack - Sheba Medical Center, Tel-Hashomer, Israel; Rosetta Genomics, Rehovot, Israel
Evaluation of microRNA Markers To Predict Outcome in Low Stage Lung Cancer
(1597)
EJ Duncavage, B Goodgame, R Govindin, JD Pfeifer - Washington University, Saint Louis, MO
miRNA Expression Profiling of Lung Adenocarcinomas: Correlation with Mutational Status
(1594)
S Dacic, S Chiosea, L Aspden, MN Nikiforova - University of Pittsburgh, Pittsburgh, PA
Genetic and Immunohistochemical Profiling of Lung Cancer in Young Adults
(1624)
N Motoi, H Nagano, K Nomura, Y Ishikawa, M Arai - Japanese Foundation for Cancer Research, Kotoku, Tokyo, Japan; Cancer Instituite Hospital, Kotoku, Tokyo, Japan
Steroid Hormone Receptor Expression and Survival in Lung Cancer
(1642)
SM Sitterding, M Tretiakova, L Faoro, R Salgia, S Conzen, AN Husain, T Krausz - University of Chicago, Chicago, IL
HER3 and c-Met Co-Expression in Non-Small and Small Cell Lung Cancers
(1616)
M Li, J Song, L Faoro, M Tretiakova, R Salgia, T Krausz, AN Husain - University of Chicago, Chicago, IL
Heparinase-1 Expression Is Progressively Increased with Increasing Stage in Non-Small Cell Lung Carcinoma and May Help Predict Recurrence in Early Stage Non-Small Cell Lung Cancer
(199)
AT Howard, JA Weber, AW Kim, X Xu, MJ Liptay, P Gattuso - Rush Medical Center, Chicago, IL
S100P Expression in 449 Non-Small Cell Lung Carcinomas: A Potential Diagnostic and Prognostic Marker
(1580)
TC Allen, PT Cagle, LR Chirieac, S Dacic, Q Zhai - The University of Texas Health Science Center at Tyler, Tyler, TX; The Methodist Hospital, Houston, TX; Brigham and Women's Hospital and Harvard Medical School, Boston, MA; University of Pittsburg School of Medicine, Pittsburg, PA
Clinicopathologic Analysis of Focal Adhesion Kinase Expression in Primary Tumors of the Lung
(1576)
A Acurio, S Charoenthammaraksa, M Tetriakova, L Faoro, R Salgia, T Krausz, AN Husain - University of Chicago, Chicago, IL
ERCC1 Expression, Gender and Leukocytosis as Prognostic Indicators in Advanced Stage Non-Small Cell Lung Carcinoma with Cisplatin-Based Chemotherapy?
(1618)
G Luo, H Bui, N Patil, J Reynolds, N Karim, M Anderson, P Pathrose, A Mehta - VA Medical Center, Cincinnati, OH; University of Cincinnati, Cincinnati, OH
Prognostic Significance of Excision Repair Cross-Complementation Group 1 Expression in Early Stage Resectable Non Small Cell Lung Cancer
(1615)
L Li, CE Sheehan, JS Ross - Albany Medical College, Albany, NY
Triple Platform Testing (IHC, FISH and Mutation) To Predict Response to Targeted Therapy in NSCLC
(1617)
D Lucas, R Camidge, R Doebele, J Haney, M Sugita, L Bemis, W Franklin - University of Colorado at Denver and Health Sciences Center, Aurora, CO
Protein Overexpression and Gene Amplification of Epidermal Growth Factor Receptor in Nonsmall Cell Lung Carcinomas: Comparison of Four Commercially Available Antibodies by Immunohistochemistry and Fluorescence In Situ Hybridization Study
(1613)
HJ Lee, XH Xu, GY Choe, DH Chung, JW Seo, CT Lee, SH Jheon, SW Sung, JH Chung - Seoul National University College of Medicine, Seongnam-Si, Gyeonggi-do, Republic of Korea; Seoul National University Bundang Hospital, Seongnam-Si, Gyeonggi-do, Republic of Korea
ERK Immunostaining Predicts EGFR and/or KRAS Mutation in Lung Adenocarcinomas, and Can Be Used To Prescreen Tumors for Subsequent Molecular Testing
(1637)
MB Ruzinova, V Joshi, D Jackman, P Janne, NI Lindeman - Brigham and Women's Hospital, Boston, MA; Beigham and Women's Hospital, Boston, MA; Dana Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA
Epidermal Growth Factor Receptor Gene Amplification in Non-Small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization Study
(1650)
SB Yoo, HJ Lee, JH Chung, DH Chung, JW Seo - Seoul National University College of Medicine, Seoul, Republic of Korea; Seoul National University Bundang Hospital, Seongnam, Republic of Korea
Amphiregulin-2 Immunoreactivity Is Superior to EGFR FISH for Predicting Favorable Response to Tyrosine Kinase Inhibitors in EGFR-Wild Type Lung Adenocarcinoma
(1585)
J Beheshti, Y Xiao, K Yonesaka, D Jackman, V Joshi, C Lee, P Janne, N Lindeman - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Harvard Partners Center for Genetics and Genomics, Boston, MA; Harvard Medical School, Boston, MA
Is TTF-1 a Predictor of EGFR Mutation in Primary Adenocarcinoma of the Lung?
(1578)
MB Alikhan, V Reddy, J Coon, P Bonomi, L Buckingham, P Gattuso - Rush University Medical Center, Chicago, IL
TTF1 Expression in Non-Small Cell Lung Carcinoma: Association with TTF1 Gene Amplification and Improved Survival
(1648)
PL Wagner, S Perner, A Soltermann, CL LaFargue, V Tischler, BA Weir, W Weder, M Meyerson, TJ Giordano, H Moch, MA Rubin - Weill Medical College of Cornell University, New York, NY; University Hospital of Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland; University of Michigan, Ann Arbor, MI; Dana Farber Cancer Institute, Boston, MA
Phenotype of Lung Adenocarcinoma with EML-ALK Fusion in the Western Population
(1635)
SJ Rodig, S Dacic, BY Yeap, JA Barletta, K Law, N Lindeman, AJ Iafrate, LR Chirieac - Brigham & Women's Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA; University of Pittsburgh, Pittsburgh, PA
Different TRAP220 Expression in Distinct Histologic Subtypes and Smoking Status of Lung Adenocarcinomas
(1636)
MS Roh, JH Yun, CH Son, DK Yang, PJ Choi, KE Lee - Dong-A University, Busan, Korea
NTRK2 Expression Predicts Improved Disease Specific Survival in Squamous Cell Carcinoma of Lung
(1645)
J Terry, A DeLuca, S Leung, G Peacock, YZ Wang, WM Elliot, D Huntsman - BC Cancer Agency, Vancouver, BC, Canada; UBC-James Hogg iCAPTURE Centre, Vancouver, BC, Canada
Notch Signaling in Non Small Cell Lung Cancers Is Associated with Squamous Differentiation and Favorable Clinical Outcome
(1614)
L Li, CE Sheehan, JS Ross - Albany Medical College, Albany, NY
Glypican-3 Preferentially Stains Lung Squamous Cell Carcinomas: A Microarray Study of 479 Non-Small Cell Lung Carcinomas
(1581)
TC Allen, PT Cagle, S Dacic, LR Chirieac, Q Zhai - The University of Texas Health Science Center at Tyler, Tyler, TX; The Methodist Hospital, Houston, TX; University of Pittsburg School of Medicine, Pittsburg, PA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Analysis of EGFR and KRA S Mutations in High-Grade Neuroendocrine Carcinomas of the Lung
(1633)
N Rekhtman, M He, C Lau, K Nafa, GJ Riely, MF Zakowski, M Ladanyi - Memorial Sloan-Kettering Cancer Center, New York, NY
Increased RASSF1 C Expression Correlates with Tumor Recurrence and Shorter Patient Survival in High-Grade Pulmonary Neuroendocrine Carcinomas
(1629)
G Pelosi, C Fumagalli, A Sonzogni, P Maisonneuve, B Del Curto, M Manzotti, D Galetta, G Viale - European Institute of Oncology and University of Milan School of Medicine, Milan, Italy; European Institute of Oncology, Milan, Italy
Ki-67 Expression in Pulmonary Neuroendocrine Tumors
(1583)
JA Barletta, L Zellos, K Law, D Sugarbaker, S Rodig, LR Chirieac - Brigham and Women's Hospital, Boston, MA
Type V Collagen Treatment Increases Caspase-9 Expression in Murine Lung Cancer
(1627)
ER Parra, CM Vargas, LC Bielecki, JMFP Ribeiro, FA Balsalobre, WR Teodoro, W de Souza, VL Capelozzi - Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
Telomere Shortening, Telomere Protein TRF1 and TRF2 Activation, and DNA Damage Response Impairement during Bronchial Carcinogenesis
(1612)
S Lantuejoul, C Raynaud, S Gazzeri, D Moro-Sibilot, D Salameire, JC Soria, E Brambilla - CHU A Michallon, Grenoble, France; CEA, Fontenay aux Roses, France; INSERM U823, IAB, University J. Fourier, Grenoble, France
Field Effect in Lung Carcinogenesis Associated with Pulmonary Fibrosis
(1599)
T Fujii, A Miyamoto, K Kishi, K Yoshimura, K Ohashi - Toranomon Hospital, Tokyo, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan
button next to any title to add to Itinerary Planner...
Add
